Literature DB >> 27920691

Primary Leiomyosarcoma in the Inferior Vena Cava Extended to the Right Atrium: A Case Report and Review of the Literature.

Shuichi Fujita1, Hideaki Takahashi1, Yumiko Kanzaki1, Tomohiro Fujisaka1, Yoshihiro Takeda1, Hideki Ozawa2, Hiroko Kuwabara3, Takahiro Katsumata2, Nobukazu Ishizaka1.   

Abstract

A 38-year-old woman had developed an abdominal distention, lower extremity edema, and dyspnea. Imaging examination revealed a large mass in the right atrium which was connected to lesions within the inferior vena cava. Although complete resection of the mass was not possible, partial surgical tumor resection was performed to avoid pulmonary embolization and circulatory collapse. Leiomyosarcoma was diagnosed histologically, and chemotherapy (doxorubicin) followed by radiotherapy was started. By reviewing papers published in the past 10 years that included 322 patients, we also discuss the clinical presentations and prognosis of leiomyosarcoma in the inferior vena cava.

Entities:  

Keywords:  Inferior vena cava; Leiomyosarcoma; Right atrium

Year:  2016        PMID: 27920691      PMCID: PMC5118828          DOI: 10.1159/000450598

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

Leiomyosarcoma is a rare, malignant mesenchymal tumor; only 218 cases had been reported as of 1996 [1]. Leiomyosarcoma of vascular origin often occurs in the inferior vena cava, and one that originated from the wall of the inferior vena cava was first reported by Perl [2] in 1871. In a previous study, it was found that patients with inferior vena cava involvement may present with lower extremity edema; however, symptoms may be nonspecific, and overall prognosis is reported to be poor, with a median survival of 2 years [3]. We herein report the case of a 38-year-old woman with primary leiomyosarcoma that was thought to originate from the inferior vena and to extend to the cardiac cavity. We also review case reports describing primary intimal sarcomas of the inferior vena cava from the past 10 years, and discuss the prevalence of symptoms and compare survival periods in this relatively recent literature.

Case Report

A 38-year-old female patient experienced abdominal distension, lower extremity edema, and dyspnea from January 20xx. Elevation of hepatic enzyme levels, ascites, and enlargement of the inferior vena cava were found, and therefore the patient was admitted to her former hospital. Further examinations revealed a mass in the right atrium which extended to the inferior vena cava and hepatic and renal veins; thus, she was referred to our department for further diagnosis and treatment. On admission, her vital signs showed a blood pressure of 138/96 mm Hg and a heart rate of 92 beats/min. Her abdomen was round and edema was present in both of the lower extremities. Chest X-ray revealed a normal cardiothoracic ratio of 48%. Electrocardiography did not show any apparent abnormal findings (fig 1); it showed a preserved left ventricular ejection fraction of 61% and a tumor 33.0 × 35.7 mm in size in the right atrium that continued to the cavity of the inferior vena cava.
Fig. 1

Chest X-ray (a) and electrocardiogram (b) on admission.

Laboratory studies showed a white blood cell count of 11,550 cells/μl, a hemoglobin level of 14.3 g/dl, a platelet count of 32.0 × 104 cells/μl, and a D-dimer level of 5.7 μg/ml. Alanine transaminase and aspartate transaminase levels were elevated to 464 and 509 U/l, respectively. The levels of carcinoembryonic antigen, α-fetoprotein, CA19-9, and CYFRA 21-1 were within normal limits, but those of CA125 (389.9 U/ml) and PIVKA-II (43 mAU/ml) were elevated. Computed tomography and magnetic resonance imaging showed dilatation of the inferior vena cava and tumor occupation between the right atrium and the inferior vena cava (fig 2a–d), ascites, and myoma of the uterus. Subsequent 18F-FDG-PET (18F-fluorodeoxyglucose positron emission tomography) showed increased nuclear uptake only in the mass in the right atrium (fig 2e, f). Coronary angiograms showed no apparent coronary artery stenosis, with small arteries feeding the tumorous lesion from the right coronary artery and the left circumflex artery (data not shown).
Fig. 2

Clinical images. a, b Coronal (a) and transverse (b) sections of computed tomography (CT) images. A tumor is visible in the right atrium that is continuously present within the inferior vena cava (arrows). c, d Coronal (c) and transverse (d) sections of magnetic resonance images. e, f Coronal (e) and transverse (f) sections of PET/CT-merged images. Increased FDG uptake may be observed in the right atrium (arrows).

Although complete resection of the tumor was considered to be difficult, a surgical approach was taken for the purpose of amelioration of hepatic congestion and avoidance of circulatory shock. The heart was exposed through a median sternotomy, and a cardiopulmonary bypass was established with an ascending aortic arterial return and venous drainage through the cannulae, one placed in the superior vena cava and the other directly into the right atrium via the appendage. The systemic temperature was reduced to 24°C, after which the circulation was interrupted and the venous blood drained into an oxygenator. The right atrium was opened down to the inferior vena caval orifice. The intra-atrial portion of the solid tumor was carefully dissected, so as to prevent embolization, and then excised. The tumor was fragmented and removed by applying hundreds of bites with pituitary rongeurs so that the caval junctions of all the hepatic veins could be fully recanalized. After full rewarming, the cardiopulmonary bypass was discontinued uneventfully. The postoperative course was uncomplicated. The tumor in the right atrial cavity, which was 48 × 45 mm in size, showed necrosis, congestion, and edema (fig 3a, b). Histologically, the tumor was composed of intersecting fascicles of abundant large spindle cells with markedly bizarre nuclei and numerous mitotic figures (10 per 10 high-power fields; fig 3c). Necrosis and myxoid degeneration were also seen. Immunohistochemically, the tumor cells were positive for α-smooth muscle actin and desmin (fig 3d, e), while they were negative for pancytokeratin, CD31, CD34, and myogenin. The Ki-67 labeling index was about 70% in the hot spot (fig 3f). Together with the clinical appearance and immunological characteristics of the tumor, a diagnosis of primary leiomyosarcoma originating from the inferior vena cava was made.
Fig. 3

Histological analysis of the tumor. a Macroscopic appearance of the tumor resected from the right atrial cavity. b Cut surface of the tumor. c Hematoxylin and eosin staining. d Staining for α-smooth muscle actin. e Staining for desmin. f Staining for Ki-67. Original magnification ×100.

The patient underwent radiotherapy (55 Gy/25 Fr), as well as chemotherapy comprising 3 courses of 60 mg/m2 doxorubicin triweekly as first-line chemotherapy, which led to a partial response. Then, the patient was administered eribulin.

Discussion

We reported a case of leiomyosarcoma originating from the inferior vena cava and extending to the right atrium. Although complete resection of the tumor was difficult, surgical treatment was selected to avoid progression of hepatic failure, pulmonary embolization [4], and circulatory collapse. After the surgery, the patient was undergoing chemo- and radiotherapy and was followed up on an outpatient basis. We also performed a PubMed literature search of the past 10 years by entering the search terms ‘leiomyosarcoma’ and ‘inferior vena cava’ [3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120]. These terms returned 196 articles with 322 cases (table 1). As reported, women were affected about 2.5-fold more often than men, although the mean age did not differ between genders (data not shown). The most prevalent symptoms were pain and/or discomfort, most frequently in the abdomen, and only 5.8% of the patients did not have any symptoms related to the leiomyosarcoma. Thus, as has been done in our patient, ultrasonographic examination may facilitate the detection of leiomyosarcoma in the inferior vena cava in subjects with gastrointestinal symptoms or edema.
Table 1

Summary of the papers on leiomyosarcoma in the inferior vena cava published during the past 10 year

Women/men/unknown, n229/92/1
Mean age ± SD, years54.4±13.7
Symptoms at presentation (n = 139), n (%)
 Pain or discomfort111 (79.9)
 Edema27 (19.4)
 Mass13 (9.4)
 Weight loss12 (8.6)
 Dyspnea9 (6.5)
Therapies, n (%)
 Chemotherapy and radiotherapy (n = 248)
  Chemotherapy alone60 (24.2)
  Radiotherapy alone48 (19.4)
  Both chemo- and radiotherapy21 (8.5)
  Neither chemo-nor radiotherapy119 (48.0)
 Surgery (n = 313)
  Surgical resection275 (88)
  No surgery38 (12)
Survival depends on the tumor's size, location, and complete surgical resection [39]; the efficacy of chemotherapy and radiotherapy is limited [109, 121]. In the current study, data regarding surgery was available for 233 patients. Those who underwent surgery (n = 217) had significantly better survival than those who did not (n = 16) (fig 4a). When patients who were reported in the papers published between 2007 and 2012 (n = 115) were compared with those reported in the papers published between 2012 and 2016 (n = 127), the prognosis was significantly better by log-rank test (fig 4b). The rate of surgical resection (either incomplete or complete) in the publication period between 2012 and 2016 (138/151; 91.4%) was found to be significantly higher than that in the period between 2007 and 2012 (137/162; 84.6%; p = 0.083 by χ2 test). The median survival period for the publication period of 2007–2016 was 6.75 years. The 5-year survival rate has been reported to be approximately 50% after complete en bloc resection [1, 122] in papers published in the last century; however, an improvement in prognosis in recent years is suggested by the literature review of the current study.
Fig. 4

Kaplan-Meier curve of the survival of the patients reported on in the past 10 years. a Subcategorized according to whether surgery had been performed or not. Patients who had undergone surgery had a significantly improved prognosis when compared with their counterparts who had not been surgically treated. b Subcategorized according to the year of publication. p values were obtained with the log-rank test.

In a recent report, Lv et al. [117] summarized the reports on 30 vascular leiomyosarcoma cases with involvement of the heart that had been listed on PubMed for the past 20 years. Of the 30 cases, 14 had right ventricular involvement. The average age at onset was 53.6 years, and there was a female dominancy (67%). The mean follow-up survival time for patients with single cardiac cavity involvement was 15 months, which seems to be much lower than without cardiac cavity involvement. In summary, we reported on a 38-year-old female patient suffering from abdominal distension, lower extremity edema, and dyspnea and diagnosed with leiomyosarcoma of the inferior vena cava extending to the right atrium. Multimodality imaging should be considered for patients with suspected symptoms – even if they are often nonspecific – for early diagnosis and therapy.

Statement of Ethics

The current case report was following the Guidelines of the Ethics Committee at Osaka Medical College.

Disclosure Statement

The authors declare that they have no conflicts of interest.
  120 in total

1.  A case of leiomyosarcoma arising from the inferior vena cava.

Authors:  Takashi Kawahara; Tohru Nakagawa
Journal:  Jpn J Clin Oncol       Date:  2012-01       Impact factor: 3.019

2.  Leiomyosarcoma of intravascular origin--a rare tumor entity: clinical pathological study of twelve cases.

Authors:  Daniel J Tilkorn; Joerg Hauser; Andrej Ring; Ole Goertz; Ingo Stricker; Hans U Steinau; Cornelius Kuhnen
Journal:  World J Surg Oncol       Date:  2010-11-22       Impact factor: 2.754

3.  An unusual case of leiomyosarcoma of the inferior vena cava in a patient with a duplicated inferior vena cava.

Authors:  Glenn Wei Leong Tan; Kok Hoong Chia
Journal:  Ann Vasc Surg       Date:  2008-09-21       Impact factor: 1.466

4.  Education and imaging. Hepatobiliary and pancreatic: Budd-Chiari syndrome secondary to leiomyosarcoma of the inferior vena cava.

Authors:  L Chia-Hsin
Journal:  J Gastroenterol Hepatol       Date:  2010-01       Impact factor: 4.029

5.  [A patient with vague inguinal complaints due to a leiomyosarcoma of the inferior caval vein].

Authors:  S A F Streukens; M R M Scheltinga; J Ebels; G van Lijnschoten; R M H Roumen; H L M Pasmans
Journal:  Ned Tijdschr Geneeskd       Date:  2007-11-17

Review 6.  Leiomyosarcoma of the Inferior Vena Cava: A Case Series and Review of the Literature.

Authors:  Eyas Alkhalili; Alissa Greenbaum; Mark Langsfeld; John Marek; Muhammed Ali Rana; Robert Glew; Itzhak Nir
Journal:  Ann Vasc Surg       Date:  2016-01-21       Impact factor: 1.466

7.  Primary leiomyosarcoma of the inferior vena cava: How should it be treated and the vein anatomy re-established?

Authors:  Ricardo Reges; Fernandes Denardi; Wagner Matheus; Ubirajara Ferreira; Nelson Rodrigues Netto; Athanase Billis
Journal:  Int J Urol       Date:  2008-03       Impact factor: 3.369

8.  Resection of the inferior vena cava for urological malignancies: single-center experience.

Authors:  Shuichi Kato; Toshiaki Tanaka; Hiroshi Kitamura; Naoya Masumori; Toshiro Ito; Nobuyoshi Kawaharada; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2012-09-06       Impact factor: 3.402

9.  Banked vena caval homograft replacement of the inferior vena cava for primary leiomyocsarcoma.

Authors:  Jae Hong Lim; Suk Ho Sohn; Yong Won Sung; Hyeon Jong Moon; Jae-Sung Choi; Se Jin Oh
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-10-05

10.  Rare case of primary inferior vena cava leiomyosarcoma on F-18 fluorodeoxyglucose positron emission tomography-computed tomography scan: Differentiation from nontumor thrombus in a background of procoagulant state.

Authors:  Natasha Singh; Divya Shivdasani; Sanket Karangutkar
Journal:  Indian J Nucl Med       Date:  2014-10
View more
  2 in total

1.  Treatment of a Double Cancer Patient With Primary Inferior Vena Cava Sarcoma and Lung Adenocarcinoma: A Case Report and Literature Review.

Authors:  Xiaohu Guo; Zhengang Wei; Mancai Wang; Youcheng Zhang
Journal:  Front Surg       Date:  2022-04-06

Review 2.  Leiomyosarcoma of the Inferior Vena Cava in an HIV-Positive Adult Patient: A Case Report and Review of the Literature.

Authors:  Jing Xu; Arash Velayati; Barbara J Berger; Ming Liu; Naga K Sucharita Cheedella; Vladimir Gotlieb
Journal:  Am J Case Rep       Date:  2017-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.